Arcutis Biotherapeutics (ARQT) Accumulated Expenses (2019 - 2026)
Arcutis Biotherapeutics' Accumulated Expenses was $146.79 million in Q2 2026, up 67.1% from $87.85 million a year earlier and up 7.2% from the prior quarter.
Arcutis Biotherapeutics (ARQT) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Arcutis Biotherapeutics came in at $116.31 million, up 74.1% from FY2024.
- Accumulated Expenses has now increased for six consecutive years, with a five-year compound annual growth rate of 49.7% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $66.79 million in FY2024 (+96.8%), $33.94 million in FY2023 (+19.8%), $28.32 million in FY2022 (+10.9%) and $25.54 million in FY2021 (+65.2%).
- The Q2 2026 figure marks the highest quarterly Accumulated Expenses in data going back to Q4 2019.
- Compared with a year earlier, Accumulated Expenses has increased for 19 straight quarters, with growth averaging 89.1% over the last eight quarters.
- The best year-over-year quarter for Accumulated Expenses over five years was Q2 2024 (growth of 126.7%); the worst was Q3 2021 (a decline of 13.7%).
- Per Business Quant data, ARQT's Accumulated Expenses in the three quarters before Q2 2026 was $136.96 million (Q1 2026), $116.31 million (Q4 2025) and $92.98 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Arcutis Biotherapeutics | 3.32 Bn | 2.60 Bn | 118.92 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 146.79 Mn |
| Mar 31, 2026 | 136.96 Mn |
| Dec 31, 2025 | 116.31 Mn |
| Sep 30, 2025 | 92.98 Mn |
| Jun 30, 2025 | 87.85 Mn |
| Mar 31, 2025 | 65.76 Mn |
| Dec 31, 2024 | 66.79 Mn |
| Sep 30, 2024 | 52.79 Mn |
| Jun 30, 2024 | 42.63 Mn |
| Mar 31, 2024 | 33.58 Mn |
| Dec 31, 2023 | 33.94 Mn |
| Sep 30, 2023 | 28.00 Mn |
| Jun 30, 2023 | 18.81 Mn |
| Mar 31, 2023 | 23.86 Mn |
| Dec 31, 2022 | 28.32 Mn |
| Sep 30, 2022 | 27.80 Mn |
| Jun 30, 2022 | 18.46 Mn |
| Mar 31, 2022 | 19.99 Mn |
| Dec 31, 2021 | 25.54 Mn |
| Sep 30, 2021 | 13.88 Mn |
Arcutis Biotherapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ARQT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();